{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T10:37:27Z","timestamp":1720262247704},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,9]]},"DOI":"10.7759\/cureus.9630","type":"journal-article","created":{"date-parts":[[2020,8,9]],"date-time":"2020-08-09T15:50:07Z","timestamp":1596988207000},"source":"Crossref","is-referenced-by-count":2,"title":["Hyper-Eosinophilic Syndrome Masquerading as Myocardial Infarction, Stroke and Cancer"],"prefix":"10.7759","author":[{"given":"Arun","family":"Minupuri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karthik","family":"Ramireddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roshni","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samia","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesus","family":"Salas Noain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-2-37","article-title":"Hypereosinophilic syndromes","volume":"2","author":"Roufosse FE","year":"2007","unstructured":"Roufosse FE, Goldman M, Cogan E. Hypereosinophilic syndromes. Orphanet J Rare Dis. 2007, 2:37. 10.1186\/1750-1172-2-37","journal-title":"Orphanet J Rare Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.09.022","article-title":"Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy","volume":"124","author":"Ogbogu PU","year":"2009","unstructured":"Ogbogu PU, Bochner BS, Butterfield JH, et al.. Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol. 2009, 124:1319-1325. 10.1016\/j.jaci.2009.09.022","journal-title":"J Allergy Clin Immunol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/01.smj.0000199745.51112.fa","article-title":"Idiopathic hypereosinophilic syndrome: a rare but fatal condition presenting with common symptoms","volume":"99","author":"Osowo A","year":"2006","unstructured":"Osowo A, Fetten J, Navaneethan S. Idiopathic hypereosinophilic syndrome: a rare but fatal condition presenting with common symptoms. South Med J. 2006, 99:188-189. 10.1097\/01.smj.0000199745.51112.fa","journal-title":"South Med J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.03.035","article-title":"Incidence of myeloproliferative hypereosinophilic syndrome in the United States and an estimate of all hypereosinophilic syndrome incidence","volume":"126","author":"Crane MM","year":"2010","unstructured":"Crane MM, Chang CM, Kobayashi MG, Weller PF. Incidence of myeloproliferative hypereosinophilic syndrome in the United States and an estimate of all hypereosinophilic syndrome incidence. J Allergy Clin Immunol. 2010, 126:179-181. 10.1016\/j.jaci.2010.03.035","journal-title":"J Allergy Clin Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-11-551614","article-title":"How I treat hypereosinophilic syndromes","volume":"126","author":"Klion AD","year":"2015","unstructured":"Klion AD. How I treat hypereosinophilic syndromes. Blood. 2015, 126:1069-1077. 10.1182\/blood-2014-11-551614","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.03.042","article-title":"Refining the definition of hypereosinophilic syndrome","volume":"126","author":"Simon HU","year":"2010","unstructured":"Simon HU, Rothenberg ME, Bochner BS, et al.. Refining the definition of hypereosinophilic syndrome. J Allergy Clin Immunol. 2010, 126:45-49. 10.1016\/j.jaci.2010.03.042","journal-title":"J Allergy Clin Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.02.042","article-title":"Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report","volume":"117","author":"Klion AD","year":"2006","unstructured":"Klion AD, Bochner BS, Gleich GJ, et al.. Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. J Allergy Clin Immunol. 2006, 117:1292-1302. 10.1016\/j.jaci.2006.02.042","journal-title":"J Allergy Clin Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa025217","article-title":"A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome","volume":"348","author":"Cools J","year":"2003","unstructured":"Cools J, DeAngelo DJ, Gotlib J, et al.. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med. 2003, 348:1201-1214. 10.1056\/NEJMoa025217","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31322-8","article-title":"Benralizumab, an anti-interleukin-5 receptor \u03b1 monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"388","author":"FitzGerald JM","year":"2016","unstructured":"FitzGerald JM, Bleecker ER, Nair P, et al.. Benralizumab, an anti-interleukin-5 receptor \u03b1 monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2016, 388:2128-2141. 10.1016\/S0140-6736(16)31322-8","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9095275","article-title":"Eosinophils from physiology to disease: a comprehensive review","volume":"2018","author":"Ramirez","year":"2018","unstructured":"Ramirez, Giuseppe A., Mona-Rita Yacoub, Marco Ripa. Eosinophils from physiology to disease: a comprehensive review. Biomed Res Int. 2018, 2018:1-28. 10.1155\/2018\/9095275","journal-title":"Biomed Res Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2015-307959","article-title":"Hypereosinophilic syndrome: cardiac diagnosis and management","volume":"102","author":"Mankad R","year":"2016","unstructured":"Mankad R, Bonnichsen C, Mankad S. Hypereosinophilic syndrome: cardiac diagnosis and management. Heart. 2016, 102:100-106. 10.1136\/heartjnl-2015-307959","journal-title":"Heart"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/36757-hyper-eosinophilic-syndrome-masquerading-as-myocardial-infarction-stroke-and-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:20:53Z","timestamp":1707506453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/36757-hyper-eosinophilic-syndrome-masquerading-as-myocardial-infarction-stroke-and-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,9]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.9630","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,9]]}}}